glp-1 prader willi Novel therapeutics in rare genetic obesities: A narrative review New commentary offers practical guidance

Fluid recommendations must be individualized when edema, heart failure or advanced kidney disease is present

Not because it introduces a new drug, but because it challenges one of the biggest assumptions in obesity medicine

Dairy is among the categories that have taken a lesser hit according to the survey, 57% of respondents state they are consuming about the same amount of dairy as they did before they started the medication compared to 28% eating less and 15% consuming more

Role of reactive oxygen species in the pathogenesis of mitochondrial DNA (mtDNA) mutations in male infertility

Effect of Glycemic Control on Cutaneous Microenvironment GLP-1 RAs limit gastric motility and promote better glycemic control